PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28944501-5	2018	In our case, local injection of interferon (IFN)-beta with dacarbazine-nimustine-vincristine therapy provided antitumor effects on an invasive tumor on the upper gingiva.	Nimustine	71-80	interferon beta 1	Homo sapiens	32-53	
15803376-1	2005	Previous investigators have reported encouraging results for malignant gliomas treated using a combination of human interferon beta (IFN-beta) with nimustine hydrochloride (ACNU) and radiation therapy (termed IAR therapy).	Nimustine	148-171	interferon beta 1	Homo sapiens	133-141	
16961130-1	2006	OBJECT: This Phase II study was performed to determine the safety, tolerability, and efficacy of combining nimustine (ACNU)-carboplatin-vincristine-Interferon-beta (IFNbeta) chemotherapy.	Nimustine	107-116	interferon beta 1	Homo sapiens	165-172	
16838652-2	2006	Since approved as a therapeutic drug for brain tumor originally produced in Japan, interferon-beta has been reported to be effective when it was used alone, in combination with chemo-radiotherapy (ACNU/MCNU as a nitrosourea derivative chemodrug, and radiation for 60 Gy totally).	Nimustine	197-201	interferon beta 1	Homo sapiens	83-98	
12622455-2	2003	Interferon-beta, ACNU as nimustine hydrochloride and radiotherapy (IAR) is a common therapy for malignant glioma in Japan.	Nimustine	17-21	interferon beta 1	Homo sapiens	0-15	
2681875-10	1989	Their results suggested that IFN-beta with ACNU was a promising regimen as a chemical modifier in radiotherapy for patients with malignant gliomas.	Nimustine	43-47	interferon beta 1	Homo sapiens	29-37